Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Atmofizer Technologies Inc C.ATMO

Alternate Symbol(s):  ATMFF

Atmofizer Technologies Inc. (Atmofizer) is a Canada-based company. The Company's consumer and industrial solutions are based on its technology for ultrafine particle agglomeration and neutralization. This capability creates a method for addressing a range of nano-scale particles, viruses and bacteria. Atmofizer develops technology to atmofize air and applies its technology in consumer and... see more

CSE:ATMO - Post Discussion

Atmofizer Technologies Inc > Patent granted
View:
Post by lscfa on Mar 09, 2022 8:59am

Patent granted

ATMOFIZER TECHNOLOGIES INC. RECEIVES NOTICE OF ALLOWANCE FROM USPTO


NEWS PROVIDED BY

Atmofizer Technologies Inc. 

Mar 09, 2022, 08:30 ET


Key Patent for Atmofizer's air purification technology

VANCOUVER, BCMarch 9, 2022 /CNW/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (Frankfurt: J3K) (OTCQB: ATMFF) announces today that the United States Patent and Trademark Office (the "USPTO") has issued a notice of allowance for claims related to the Company's air and water purification technology.

The allowed patent application, titled, "Ultra-Fine Particle Aggregation, Neutralization and Filtration" (US Patent Application No. 17/471,610) provides broad protection for the application of the Company's air and water purification technology.

"This notice of allowance provides further validation of our novel approach to air and water purification technology and enables Atmofizer to confidently pursue further development of its technology." said Olivier Centner, Chief Executive Officer of Atmofizer Technologies Inc.

Joel Weiss, Managing Partner of Weiss & Arons, LLP, and Atmofizer's IP counsel, stated, "allowance of the Atmofizer Patent validates the Atmofizer technological solutions to real technological problems and signifies the relevance, on a go-forward basis, of Atmofizer in the air and water purification markets."

Olivier further states, "This patent is a critical step in protecting our technology and establishing ourselves as the leaders in purifying air from even the smallest ultra fine particles, the ones that get past our bodies natural defenses, into our blood and even our brains. COVID has raised awareness of air quality, the market is growing exponentially and Joel and his team have done a fantastic job ensuring we protect our technology so we can focus on commercialization."

A notice of allowance is issued after the USPTO makes the determination that a patent should be granted from an application. A patent from the recently allowed application is pending issuance and is expected to be issued in the near future.

Be the first to comment on this post